Conference Coverage

ASTRO: Metformin use during radiotherapy associated with better gynecologic cancer outcomes


 

AT THE ASTRO ANNUAL MEETING

References

Metformin could have an effect on radiation response, she noted, but “it is something we have only been seeing in the retrospective studies presented today, but it would be interesting to look at this in a prospective study.”

Pages

Recommended Reading

Recognizing and treating vulvar cancer
MDedge Hematology and Oncology
Nonselective beta-blockers boost ovarian cancer survival
MDedge Hematology and Oncology
Cervical cancer screening guidelines slow to gain traction
MDedge Hematology and Oncology
Early results encouraging for nivolumab in ovarian cancer patients
MDedge Hematology and Oncology
New cancer cases to reach nearly 2.4 million in 2035 – AACR
MDedge Hematology and Oncology
Vulvar intraepithelial neoplasia: Changing terms and therapy trends
MDedge Hematology and Oncology
Adjuvant hormone therapy may improve survival in epithelial ovarian cancer
MDedge Hematology and Oncology
Power morcellation risks increase with age
MDedge Hematology and Oncology
Managing menopausal symptoms after risk-reducing salpingo-oophorectomy
MDedge Hematology and Oncology
Tomotherapy may decrease radiation-induced bowel toxicity in cervical cancer
MDedge Hematology and Oncology